REducing Colonoscopies in patients without significant bowEl DiseasE: the RECEDE Study - protocol for a prospective diagnostic accuracy study.

ABSTRACT:

Introduction

Demand for colonoscopies and CT colonography (CTC) is exceeding capacity in National Health Service Trusts. In many patients colonoscopies and CTCs show no significant bowel disease (SBD). Faecal Immunochemical Testing (FIT) is being introduced to prioritise patients for colonoscopies but is insufficient to identify non-SBD patients meaning colonoscopy and CTC demand remains high. The REducing Colonoscopies in patients without significant bowEl DiseasE (RECEDE) study aims to test urine volatile organic compound (VOC) analysis alongside FIT to improve detection of SBD and to reduce the number of colonoscopies and CTCs.

Methods and analysis

This is a multicentre, prospective diagnostic accuracy study evaluating whether stool FIT plus urine VOC compared with stool

SUBMITTER: Bradley C 

PROVIDER: S-EPMC8968545 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature